Knowledge hub

Business

News

New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis

Ardigen Collaborates on Breakthrough in TCR Therapy Advancements
Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
News

Discover Our Gene Regulation Platform

Ardigen – New Corporate Identity
Prof. Olivera Finn joined Ardigen’s Scientific Board